# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015757
Filing Date
2018-11-13
Accepted
2018-11-13 16:17:06
Documents
89
Period of Report
2018-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 1084391
2 |  | ex10-1.htm | EX-10.1 | 75449
3 |  | ex10-2.htm | EX-10.2 | 78004
4 |  | ex10-3.htm | EX-10.3 | 79069
5 |  | ex31-1.htm | EX-31.1 | 18421
6 |  | ex31-2.htm | EX-31.2 | 18190
7 |  | ex32-1.htm | EX-32.1 | 9378
| Complete submission text file | 0001493152-18-015757.txt |  | 5060092

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE FILE | immy-20180930.xml | EX-101.INS | 706682
9 | XBRL SCHEMA FILE | immy-20180930.xsd | EX-101.SCH | 54939
10 | XBRL CALCULATION FILE | immy-20180930_cal.xml | EX-101.CAL | 87038
11 | XBRL DEFINITION FILE | immy-20180930_def.xml | EX-101.DEF | 291641
12 | XBRL LABEL FILE | immy-20180930_lab.xml | EX-101.LAB | 372571
13 | XBRL PRESENTATION FILE | immy-20180930_pre.xml | EX-101.PRE | 343048

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 181178183
SIC: 2834 Pharmaceutical Preparations